Colorized scanning electron micrograph of a cell (purple) infected with the Omicron strain of SARS-CoV-2 virus particles (green), isolated from an individual. Image captured at…
Posts published in “National Institute of Allergy and Infectious Diseases”
Auto Added by WPeMatico
Scientists found that IV administration of the vaccine boosted the number of cytotoxic T cells capable of infiltrating and attacking tumor cells and engaged the…
A cryoelectron microscopic reconstruction model of the Epstein-Barr virus gp350-ferritin nanoparticle. Credit: Geng Meng, Purdue University The National Institute of Allergy and Infectious Diseases (NIAID),…
Study Includes Multiple Variant Vaccines Adults interested in joining this study should visit ClinicalTrials.gov and search identifier NCT05289037 for a list of sites and contacts.…
Scanning electron micrograph of an HIV-infected H9 T cell. Credit: NIAID Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National…
Achieving classical herd immunity against SARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the official name of the virus strain that causes coronavirus disease (COVID-19).…
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand rare but potentially serious systemic…
NIAID-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19First identified in 2019 in Wuhan, China, Coronavirus disease 2019 (COVID-19) is…
A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3…
Transmission electron micrograph of SARS-CoV-2 virus particles (gold) within endosomes of a heavily infected nasal Olfactory Epithelial Cell. Credit: NIAID A growing body of scientific…
Scanning electromicrograph of an HIV-infected H9 T cell. Credit: NIAID NIH scientists developed vaccine platform. An experimental HIV vaccine based on mRNA—the same platform technology…
CT scan of patient’s lungs showing COVID-19 damage in red. Credit: Gerlig Widmann and team, Department of Radiology, Medical University of Innsbruck SARS-CoV-2 prevents lung…
Credit: NIAID Integrated Research Facility The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $36.3…
Colorized scanning electron micrograph of a cell (blue) infected with SARS-CoV-2 (purple). Credit: NIAID Trial also will test pausing immunosuppressive medication to improve antibody response.…
Colorized electron micrograph showing malaria parasite (right, blue) attaching to a human red blood cell. The inset shows a detail of the attachment point at…
This colorized transmission electron micrograph shows a SARS-CoV-2 virus particle, isolated from a patient. Credit: NIAID The combination of baricitinib, an anti-inflammatory drug, and remdesivir,…
Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick,…
Colorized scanning electron micrograph of an apoptotic cell (red) infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID…
Transmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility in Fort Detrick, Maryland.…
Vial of investigational Janssen COVID-19 vaccine. Credit: The Janssen Pharmaceutical Companies of Johnson & Johnson A fourth Phase 3 clinical trial evaluating an investigational vaccine…